Person who experienced the adverse event (patient)
Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5195460 | 6206065 | I | 5195460-5 | 20051101 | 20061221 | 20061230 | EXP | JP-ABBOTT-06P-087-0354120-00 | ABBOTT | M | Y | 62 | KG | 20061230 | MD | 20060208 | JAPAN |
Drug(s) used by person
Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
---|---|---|---|---|---|---|---|---|---|---|---|
5195460 | 1007999565 | PS | NORVIR | 1 | ORAL | UNKNOWN | 020945 | ||||
5195460 | 1007999566 | C | LAMIVUDINE | 1 | ORAL | ||||||
5195460 | 1007999567 | C | EFAVIRENZ | 1 | ORAL | ||||||
5195460 | 1007999568 | C | TENOFOVIR | 2 | ORAL | ||||||
5195460 | 1007999569 | C | ATAZANAVIR | 2 | ORAL |
Indications of drugs used
Event ID | DRUG SEQ | INDI PT |
---|---|---|
5195460 | 1007999565 | HIV INFECTION |
5195460 | 1007999566 | HIV INFECTION |
5195460 | 1007999567 | HIV INFECTION |
5195460 | 1007999568 | HIV INFECTION |
5195460 | 1007999569 | HIV INFECTION |
Outcome of event
Event ID | OUTC COD |
---|---|
5195460 | DE |
5195460 | LT |
Reactions reported
Event ID | PT |
---|---|
5195460 | DISSEMINATED INTRAVASCULAR COAGULATION |
5195460 | DISSEMINATED TUBERCULOSIS |
5195460 | GASTROINTESTINAL HAEMORRHAGE |
5195460 | KAPOSI'S SARCOMA |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|
5195460 | 1007999565 | 20060111 | 20060130 | ||
5195460 | 1007999566 | 20060105 | 20060130 | ||
5195460 | 1007999567 | 20060105 | 20060110 | ||
5195460 | 1007999568 | 20060105 | 20060130 | ||
5195460 | 1007999569 | 20060111 | 20060130 |